Li X - Search Results

1

Cardiac microvascular barrier function mediates the protection of Tongxinluo against myocardial ischemia/reperfusion injury.

Qi K, Li L, Li X, Zhao J, Wang Y, You S, Hu F, Zhang H, Cheng Y, Kang S, Cui H, Duan L, Jin C, Zheng Q, Yang Y. Qi K, et al. Among authors: li x, li l. PLoS One. 2015 Mar 17;10(3):e0119846. doi: 10.1371/journal.pone.0119846. eCollection 2015. PLoS One. 2015. PMID: 25781461 Free PMC article.

2

Tongxinluo reduces myocardial no-reflow and ischemia-reperfusion injury by stimulating the phosphorylation of eNOS via the PKA pathway.

Li XD, Yang YJ, Geng YJ, Jin C, Hu FH, Zhao JL, Zhang HT, Cheng YT, Qian HY, Wang LL, Zhang BJ, Wu YL. Li XD, et al. Am J Physiol Heart Circ Physiol. 2010 Oct;299(4):H1255-61. doi: 10.1152/ajpheart.00459.2010. Epub 2010 Aug 6. Am J Physiol Heart Circ Physiol. 2010. PMID: 20693395 Free article.

3

No-reflow disrupts the expression and distribution of connexin 43 in a swine model.

Cheng YT, Yang YJ, Zhang HT, Li XD, Kang S, Qian HY, Zhao JL. Cheng YT, et al. Microvasc Res. 2011 Nov;82(3):404-9. doi: 10.1016/j.mvr.2011.07.002. Epub 2011 Jul 21. Microvasc Res. 2011. PMID: 21810432

4

PKA-mediated eNOS phosphorylation in the protection of ischemic preconditioning against no-reflow.

Li XD, Cheng YT, Yang YJ, Meng XM, Zhao JL, Zhang HT, Wu YJ, You SJ, Wu YL. Li XD, et al. Microvasc Res. 2012 Jul;84(1):44-54. doi: 10.1016/j.mvr.2012.04.002. Epub 2012 Apr 14. Microvasc Res. 2012. PMID: 22542438

5

Phosphorylation of endothelial NOS contributes to simvastatin protection against myocardial no-reflow and infarction in reperfused swine hearts: partially via the PKA signaling pathway.

Li XD, Yang YJ, Geng YJ, Zhao JL, Zhang HT, Cheng YT, Wu YL. Li XD, et al. Acta Pharmacol Sin. 2012 Jul;33(7):879-87. doi: 10.1038/aps.2012.27. Epub 2012 Jun 4. Acta Pharmacol Sin. 2012. PMID: 22659627 Free PMC article.

6

The cardioprotection of simvastatin in reperfused swine hearts relates to the inhibition of myocardial edema by modulating aquaporins via the PKA pathway.

Li XD, Yang YJ, Geng YJ, Cheng YT, Zhang HT, Zhao JL, Yuan JQ, Gao RL. Li XD, et al. Int J Cardiol. 2013 Sep 10;167(6):2657-66. doi: 10.1016/j.ijcard.2012.06.121. Epub 2012 Jul 21. Int J Cardiol. 2013. PMID: 22819122

7

[Ischemic preconditioning attenuates myocardial no-reflow and reperfusion injury after revascularization of acute myocardial infarction by reducing myocardial edema via the protein kinase A pathway].

Li XD, Yang YJ, Zhao JL, Zhang HT, Cheng YT, Tian Y, Meng XM, Cui HH, Wang TJ. Li XD, et al. Zhonghua Xin Xue Guan Bing Za Zhi. 2012 Nov;40(11):945-51. Zhonghua Xin Xue Guan Bing Za Zhi. 2012. PMID: 23363677 Chinese.

8

Protein kinase A-mediated cardioprotection of Tongxinluo relates to the inhibition of myocardial inflammation, apoptosis, and edema in reperfused swine hearts.

Li XD, Yang YJ, Cheng YT, Dou KF, Tian Y, Meng XM. Li XD, et al. Chin Med J (Engl). 2013;126(8):1469-79. Chin Med J (Engl). 2013. PMID: 23595379

9

Effect of pre-procedural statin therapy on myocardial no-reflow following percutaneous coronary intervention: a meta analysis.

Li XD, Yang YJ, Hao YC, Yang Y, Zhao JL, Dou KF, Gu DF. Li XD, et al. Chin Med J (Engl). 2013;126(9):1755-60. Chin Med J (Engl). 2013. PMID: 23652063

10

Induction of autophagy by Tongxinluo through the MEK/ERK pathway protects human cardiac microvascular endothelial cells from hypoxia/reoxygenation injury.

Cui H, Li X, Li N, Qi K, Li Q, Jin C, Zhang Q, Jiang L, Yang Y. Cui H, et al. Among authors: li x, li n, li q. J Cardiovasc Pharmacol. 2014 Aug;64(2):180-90. doi: 10.1097/FJC.0000000000000104. J Cardiovasc Pharmacol. 2014. PMID: 24705173

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

180,907 results

Search Page

Filters